Rigel Pharmaceuticals (RIGL) to Report Q1 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 04/28/26
Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial ResultsPRNewsWire • 04/28/26
Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock?Zacks Investment Research • 04/24/26
Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (Rating Upgrade)Seeking Alpha • 04/09/26
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical OncologyPRNewsWire • 03/31/26
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatePRNewsWire • 03/03/26
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 02/24/26
IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential?Zacks Investment Research • 02/24/26
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business UpdatePRNewsWire • 02/24/26
Will Tavalisse Continue to Drive Rigel Pharmaceuticals' Growth in 2026?Zacks Investment Research • 02/18/26
FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside?Zacks Investment Research • 01/28/26
Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and ExpositionPRNewsWire • 12/07/25